| Literature DB >> 32046780 |
Sileye Mamadou Diallo1,2,3, Hervé Bogreau2,3,4, Nasserdine Papa Mze2,3, Mohamed Salem Ould Ahmedou Salem1, Mohamed Lemine Ould Khairy5,6, Philippe Parola2,3, Leonardo Basco2,3, Ali Ould Mohamed Salem Boukhary7,8.
Abstract
BACKGROUND: Plasmodium falciparum malaria is endemic in the southern sahelian zone of Mauritania where intense internal and trans-border human and livestock movement occurs. The risk of importation and spread of drug-resistant parasites need to be regularly assessed in this region. The objective of the study was to assess the recent malaria situation near the Mauritania-Mali border.Entities:
Keywords: Cross-border malaria; Drug resistance; Epidemiology; Plasmodium falciparum; Plasmodium vivax; Sahel
Year: 2020 PMID: 32046780 PMCID: PMC7014702 DOI: 10.1186/s40249-020-0634-5
Source DB: PubMed Journal: Infect Dis Poverty ISSN: 2049-9957 Impact factor: 4.520
Fig. 1Map showing the location of Kobeni city. The blue line indicates paved roads. The road connecting Nouakchott and Aioun is part of ‘Route de l’Espoir’ which continues eastward from Aioun and ends at the city of Néma in southeastern Mauritania
Characteristics of febrile and malaria-infected patients consulting at Kobeni health centre in Hodh Elgharbi region, southeastern Mauritania, during 2015–2017
| Characteristics | Study year | |||
|---|---|---|---|---|
| 2015 | 2016 | 2017 | 2015–2017 | |
| Number | 1247 | 566 | 513 | 2326 |
| Gender | ||||
| Female, | 640 (51.3) | 311 (54.9) | 287 (56.0) | 1238 (53.2) |
| Male, | 607 (48.7) | 255 (45.1) | 226 (44.0) | 1088 (46.8) |
| Age group (year) | ||||
| < 5, | 138 (11.1) | 77 (13.6) | 44 (8.6) | 259 (11.1) |
| 5–9, | 192 (15.4) | 103 (18.2) | 67 (13.1) | 362 (15.6) |
| 10–14, | 175 (14.0) | 82 (14.5) | 68 (13.2) | 325 (14.0) |
| ≥ 15, | 742 (59.5) | 304 (53.7) | 334 (65.1) | 1380 (59.3) |
| Mean axillary temperature (range) (°C) | 38.7 (37.5–40.9) | 38.8 (37.5–40.5) | 38.6 (37.5–40.9) | 38.7 (37.5–40.9) |
| GMPDa (asexual parasites/μl) | 1990 | 1860 | 2640 | 1100 |
| PCR-positive by age group (years) | ||||
| < 5, | 71 (9.0) | 32 (11.2) | 22 (7.6) | 125 (9.2) |
| 5–9, | 138 (17.6) | 53 (18.5) | 39 (13.5) | 230 (16.9) |
| 10–14, | 113 (14.4) | 43 (15.0) | 39 (13.5) | 195 (14.3) |
| ≥ 15, | 464 (59.0) | 158 (55.2) | 189 (65.4) | 811 (59.6) |
| Ethno-linguistic groups | ||||
| Moorsb | 1101 (88.3) | 502 (88.6) | 437 (85.1) | 2040 (87.7) |
| Black Africansc | 146 (11.7) | 64 (11.4) | 76 (14.9) | 286 (12.3) |
aGeometric mean of parasite density
bMoors refer to ethno-linguistic group speaking Hassaniya, a Berber-influenced Arabic dialect
cBlack Africans refer to ethnic groups (Pular [also known as Fulan], Soninke, Wolof and Bambara [the main ethnic group in Mali])
Proportions of malaria-positive tests by diagnostic methods among febrile patients consulting at Kobeni health centre in Hodh Elgharbi region, south-eastern Mauritania, during 2015–2017a
| Number (%) of patients | ||
|---|---|---|
| Microscopy | PCRb | |
| 1143 (99.7) | 1205 (88.5) | |
| 0 | 47 (3.5) | |
| 2 (0.2) | 0 | |
| 1 (0.1) | 3 (0.2) | |
| 0 | 99 (7.3) | |
| 0 | 6 (0.4) | |
| 0 | 1 (0.07) | |
aResults are expressed as the number of malaria-positive samples and the proportions of malaria species among 1146/2326 (49.3%) samples that were positive by microscopic examination and 1361/2281 (59.7%) samples that were positive by PCR
bPCR was not performed in 45 febrile patients due to the absence of dried blood spots. RDT was positive for P. falciparum, with or without other Plasmodium spp., in 1232/2326 (53.0%)
Fig. 2The number of presumptive malaria cases among febrile patients and number of PCR-positive cases at Kobeni health centre in 2015–2017. The red horizontal bars denote the total annual rainfall and the duration of rainy season for each year. Patients were not recruited during the dry season (January–July) in 2017
Origin, travel history, and malaria positivity among febrile patients consulting at Kobeni health centre in Hodh Elgharbi region, south-eastern Mauritania, during 2015–2017
| Number (%) of patientsa | ||
|---|---|---|
| Febrile | PCR-positive | |
| Origin | ||
| From Kobeni commune | 1535 (67.3) | 899 (66.1) |
| From outside Kobeni | 746 (32.7) | 462 (33.9) |
| Travel history | ||
| External travelb | 31 (30.4) | 18 (34.0) |
| Internal travelc | 71 (69.6) | 35 (66.0) |
| No travel history outside Kobeni department (commune of residence) | ||
| Kobeni city | 1464 (67.3)d | 864 (59.0)e |
| Gougui Zemmal | 168 (7.7)d | 102 (60.7)e |
| El Hassi | 245 (11.2)d | 150 (61.2)e |
| Medbougou | 221 (10.1)d | 147 (66.5)e |
| Leghlig | 29 (1.3)d | 13 (44.8)e |
| El Voulaniya | 46 (2.1)d | 29 (63.0)e |
| Timizine | 6 (0.3)d | 3 (50.0)e |
aPCR was performed in 2281 febrile patients
bFrom Côte d’Ivoire, Republic of Congo, Mali, or Senegal (3/18 of PCR-confirmed malaria patients were Malians arriving from Mali)
cinternal travel refers to patients who had travelled to malaria endemic zones in southern Mauritania or to the northern zone where P. vivax is known to be endemic (Nouakchott and Atar)
dPercentages of febrile cases without any travel history in each commune (denominator, 2179)
eMalaria infection rate in each commune, defined as the number of PCR-positive malaria cases among febrile cases in each commune
Bed net use and malaria infections among febrile patient consulting at Kobeni health centre in Hodh Elgharbi region, southeastern Mauritania, during 2015–2017
| Bed net usea | Number (%) of patients | ||||
|---|---|---|---|---|---|
| Malaria positive | Malaria negative | Odd ratio (95% | |||
| Yes | 1637 (71.8) | 987 (60.3) | 650 (39.7) | 1.1 (0.91–1.32) | 0.33 |
| No | 644 (28.2) | 374 (58.1) | 270 (41.9) | ||
aInformation on the use of bed net was available from 2281/2326 (98.1%) patients. Among those who own bed nets, a large majority of patients reported to have both insecticide-impregnated and non-impregnated bed nets
Antimalarials used to treat malaria infections in patient consulting at Kobeni health center in Hodh Elgharbi region, southeastern Mauritania, during 2015–2017
| Year | ||||||
|---|---|---|---|---|---|---|
| Quinine | ASAQ | AL | SP | CQ | AS-SP | |
| 2015 | 703 (64.4) | 23 (1.8) | 2 (0.2) | 27 (2.2) | 31 (2.5) | 17 (1.4) |
| 2016 | 296 (52.3) | 0 | 1 (0.2) | 0 | 7 (1.2) | 3 (0.5) |
| 2017 | 284 (55.3) | 0 | 0 | 0 | 0 | 0 |
| Total | 1283 (55.2) | 23 (1) | 3 (0.1) | 27 (1.2) | 38 (1.6) | 65 (0.9) |
ASAQ Artesunate-amodiaquine, AL Artesunate-lumefantrine, SP Sulfadoxine-pyrimethamine, CQ Chloroquine, AS-SP Artesunate-sulfamethoxypyrazine-pyrimethamine